Between 24th and 26th September, Boston will host the NGS for cancer drug development seminar. Leading drug companies such as Merck, AstraZeneca and cancer centers such as Dana Farber Cancer Institute will share their research case studies and best practices on topics that range from microarray technology, bioinformatics standards, biomarker discovery to treatment decisions for personalized medicine. For registering to this event, please visit http://ngs-cancer.com/register
Please visit us at Reg4All and register for free. Get connected to the clinical study that is right for you.